Phenylspirodrimane with Moderate Reversal Effect of Multidrug Resistance Isolated from the Deep-Sea Fungus Stachybotrys sp. 3A00409 DOI Creative Commons
Xinhua Ma, Min Wu, Zhenwei Chen

et al.

Molecules, Journal Year: 2024, Volume and Issue: 29(7), P. 1685 - 1685

Published: April 8, 2024

Two new phenylspirodrimanes, stachybotrins K and L (1 2), together with eight known analogues (3–10), were isolated from deep-sea-derived Stachybotrys sp. MCCC 3A00409. Their structures determined by extensive NMR data mass spectroscopic analysis. Absolute configurations of compounds through a comparison their circular dichroism (CD) spectra other reported compounds. The possible reversal effects all assayed in the resistant cancer cell lines. Stachybotrysin B (8) can reverse multidrug resistance (MDR) ABCB1-overexpression cells (KBv200, Hela/VCR) at non-cytotoxic concentration. Doxorubicin accumulation assay molecular-docking analysis reveal that mechanism its MDR effect may be related to increase intracellular concentration substrate anticancer drugs.

Language: Английский

Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review DOI
Jinyun Dong, Yuan Li, Can Hu

et al.

Pharmacology & Therapeutics, Journal Year: 2023, Volume and Issue: 249, P. 108488 - 108488

Published: July 11, 2023

Language: Английский

Citations

71

Recent advances on anticancer and antimicrobial activities of directly-fluorinated five-membered heterocycles and their benzo-fused systems DOI Creative Commons
Ashraf A. Abbas, Thoraya A. Farghaly, Kamal M. Dawood

et al.

RSC Advances, Journal Year: 2024, Volume and Issue: 14(28), P. 19752 - 19779

Published: Jan. 1, 2024

The fluorinated heterocycles are main components of 20% the anticancer and antibiotic drugs, this review describes reported antimicrobial activities five-membered their benzo-fused systems.

Language: Английский

Citations

10

Design, synthesis, and bioactivity evaluation of novel indole-selenide derivatives as P-glycoprotein inhibitors against multi-drug resistance in MCF-7/ADR cell DOI
Zhikun Yang,

Disheng Luo,

Chen Shao

et al.

European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 268, P. 116207 - 116207

Published: Feb. 10, 2024

Language: Английский

Citations

9

Furan and benzofuran derivatives as privileged scaffolds as anticancer agents: SAR and docking studies (2010 to till date) DOI
Preeti Patel, Ruchi Shakya,

Vishakha Vishakha

et al.

Journal of Molecular Structure, Journal Year: 2023, Volume and Issue: 1299, P. 137098 - 137098

Published: Nov. 15, 2023

Language: Английский

Citations

18

Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein DOI Creative Commons
Jerónimo Laiolo, Dafni G. Graikioti,

Cecilia L. Barbieri

et al.

Scientific Reports, Journal Year: 2024, Volume and Issue: 14(1)

Published: Jan. 2, 2024

Abstract Chemotherapy is a powerful means of cancer treatment but its efficacy compromised by the emergence multidrug resistance (MDR), mainly linked to efflux transporter ABCB1/P-glycoprotein (P-gp). Based on chemical structure betulin, identified in our previous work as an effective modulator P-gp function, series analogs were designed, synthesized and evaluated source novel inhibitors. Compounds 6g 6i inhibited rhodamine 123 overexpressed leukemia cells, K562/Dox, at concentrations 0.19 µM 0.39 µM, respectively, increased intracellular accumulation doxorubicin submicromolar concentration 0.098 µM. able restore sensitivity K562/Dox Dox 0.024 respectively. Structure–activity relationship analysis molecular modeling revealed important information about structural features conferring activity. All active compounds fitted specific region involving transmembrane helices (TMH) 4–6 from one homologous half TMH 7 12 other, also showing close contacts with 6 12. that bound preferentially another inactive, regardless their free energy binding. It should be noted devoid toxic effects against peripheral blood mononuclear normal cells erythrocytes. The data obtained indicates both might proposed scaffolds for obtaining promising inhibitors overcoming MDR.

Language: Английский

Citations

5

Design, Synthesis, and Biological Activity Study of 6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline Derivatives Against Multidrug Resistance in Eca109/Vcr Cells DOI
Qin Ouyang, Bo Xu, Tao Yu

et al.

Published: Jan. 1, 2025

Language: Английский

Citations

0

Potential of plant-derived compounds to reverse multidrug resistance in breast cancer cell lines DOI
Elcilene Alves de Sousa, João Paulo da Silva Gomes,

Márcia Denise Alves Veras

et al.

Elsevier eBooks, Journal Year: 2025, Volume and Issue: unknown, P. 97 - 110

Published: Jan. 1, 2025

Language: Английский

Citations

0

Design, Synthesis, and Biological Activity Study of 6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline Derivatives Against Multidrug Resistance in Eca109/VCR Cells DOI
Bo Xu, Tao Yu,

Hong-Yuan Liu

et al.

European Journal of Medicinal Chemistry, Journal Year: 2025, Volume and Issue: unknown, P. 117542 - 117542

Published: March 1, 2025

Language: Английский

Citations

0

Recent developments of P-glycoprotein inhibitors and its structure–activity relationship (SAR) studies DOI
Xuanming Zhao, Jing Di,

Dingjie Luo

et al.

Bioorganic Chemistry, Journal Year: 2023, Volume and Issue: 143, P. 106997 - 106997

Published: Nov. 25, 2023

Language: Английский

Citations

8

Discovery of 2,5-disubstituted furan derivatives featuring a benzamide motif for overcoming P-glycoprotein mediated multidrug resistance in MCF-7/ADR cell DOI
Zhikun Yang, Yue Cai,

Shen Mao

et al.

European Journal of Medicinal Chemistry, Journal Year: 2023, Volume and Issue: 257, P. 115462 - 115462

Published: May 12, 2023

Language: Английский

Citations

7